Clinical and economic profile of entecavir in the treatment of chronic hepatitis b virus infection
HBV infection in Italy is frequently underestimated, raising the risk of important complications, such as cirrhosis and hepatocellular carcinoma, and thus increasing mortality. In infections phases requiring treatment, it’s possible to choose among the currently available drugs: interferons, nucleos...
Main Author: | Mario Eandi |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd Medical Publishers
2011-06-01
|
Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
Subjects: | |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/72 |
Similar Items
-
[Tenofovir and entecavir for chronic hepatitis B infection treatment: a single-center experience]
by: Fabio Tarsetti, et al.
Published: (2015-12-01) -
Performance evaluation of the HepB Typer-Entecavir kit for detection of entecavir resistance mutations in chronic hepatitis B
by: Sang Hoon Ahn, et al.
Published: (2013-12-01) -
Severe Acute Hepatitis B Treated with Entecavir
by: Andrea Tosti, et al.
Published: (2011-01-01) -
Comparative role of tenofovir versus entecavir for treating patients with hepatitis B virus-related acute on chronic liver failure
by: Sharker M. S. Hossain, et al.
Published: (2021-01-01) -
Entecavir Treatment in Children and Adolescents with Chronic Hepatitis B Virus Infection
by: Kai-Chi Chang, et al.
Published: (2016-10-01)